Document is current
Any future updates will be listed below
-
Authors
Losi, Giulia https://orcid.org/0009-0004-2640-3155
Mussetti, Alberto
Peña, Marta https://orcid.org/0000-0001-6601-7276
Lopez-Pereira, Patricia
Sureda, Anna https://orcid.org/0000-0002-1238-6970
Novelli, Silvana https://orcid.org/0000-0001-8750-0195
- License Information
-
More Information
Article History
Received: 3 October 2024
Revised: 29 November 2024
Accepted: 3 December 2024
First Online: 14 December 2024
Competing interests
: GL, SN, AM, MP, and PL have no conflicts of interest. Anna Sureda’s conflicts of interest: honoraria: Takeda, BMS/Celgene, MSD, Janssen, Amgen, Novartis, Gilead Kite, Sanofi, Roche, GenMab, Abbvie, Jazz Pharmaceuticals; consultancy: Takeda, BMS/Celgene, Novartis, Janssen, Gilead, Sanofi, GenMab, Abbvie; speaker’s Bureau: Takeda; research Support: Takeda; non-profit organizations: Presidency of the EBMT.
